GSK's ₹.400 cr investment approved by FIPB.

التفاصيل البيبلوغرافية
العنوان:	GSK's ₹.400 cr investment approved by FIPB.
المصدر:	BioSpectrum. Feb2014, Vol. 12 Issue 2, p10-10. 1/4p.
الشركة/الكيان:	INDIA. Dept. of Economic Affairs. Foreign Investment Promotion Board , GLAXOSMITHKLINE
مستخلص:	The article reports on the approval by Foreign Investment Promotion Board (FIPB) in India on the proposed investment of British healthcare company GlaxoSmithKline (GSK) to Indian pharmaceutical sector.
قاعدة البيانات:	Business Source Index

الوصف
الوصف غير متاح.